RELAY THERAPEUTICS INC (RLAY) Stock Earnings & Estimates
NASDAQ:RLAY - US75943R1023 - Common Stock
4.12 USD
+0.12 (+3%)
4.2 USD
+0.08 (+1.94%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.38M -54.46% | 25.546M 1,751.16% | 10.007M -60.83% | 13.164M 31.55% | 11.89M -9.68% | 26.607M 123.78% | 12.726M -52.17% | 126.74M 895.91% | 325.2M 156.59% | 698.08M 114.66% | 963.04M 37.96% | |
| EBITDA YoY % growth | -295.15M 15.41% | -367.731M -24.59% | -367.004M 0.20% | -361.116M 1.60% | -372.106M -3.04% | -348.309M 6.40% | -293.168M 15.83% | -132.07M 54.95% | 75.398M 157.09% | 232.1M 207.83% | 367.43M 58.31% | |
| EBIT YoY % growth | -299.28M 15.18% | -373M -24.63% | -372.468M 0.14% | -317.102M 14.86% | -314.623M 0.78% | -318.067M -1.09% | -277.943M 12.61% | -224.098M 19.37% | -61.667M 72.48% | 204.75M 432.02% | 350.86M 71.36% | |
| Operating Margin | -21,686.96% | -1,460.11% | -3,722.07% | -2,408.86% | -2,646.11% | -1,195.43% | -2,184.06% | -176.82% | -18.96% | 29.33% | 36.43% | |
| EPS YoY % growth | -2.60 32.47% | -2.80 -7.69% | -2.39 14.64% | -1.71 28.51% | -1.66 2.60% | -1.82 -9.51% | -1.18 35.26% | -0.87 26.23% | -0.19 78.12% | 0.69 464.22% | 1.10 58.82% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.43 32.29% | -0.39 13.04% | -0.41 10.71% | -0.41 -0.51% | -0.38 10.21% | -0.35 9.29% | -0.38 8.11% | -0.38 8.42% | -0.37 4.13% | -0.30 16.67% |
| Revenue Q2Q % growth | 186.517K | 6.512M | 33.997K -99.56% | 33.997K -94.98% | 204K 9.37% | 8.007M 22.96% | 81.6K 140.02% | 81.6K 140.02% | 81.6K -60.00% | 15.382M 92.11% |
| EBITDA Q2Q % growth | -80.58M 12.64% | -74.45M 6.37% | -71.033M 15.09% | -72.42M 2.97% | -72.42M 10.13% | -58.14M 21.91% | -74.46M -4.82% | -75.48M -4.23% | -76.5M -5.63% | -62.22M -7.02% |
| EBIT Q2Q % growth | -79.318M 17.69% | -72.21M 15.03% | -76.699M 9.63% | -77.971M -1.46% | -69.967M 11.79% | -61.766M 14.46% | -75.674M 1.34% | -76.439M 1.96% | -77.204M -10.34% | -62.679M -1.48% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.41 40.58% | -0.50 | 0.09 | 18.23% |
| Q1 2025 Q2Q % growth | -0.46 25.81% | -0.50 | 0.04 | 7.59% |
| Q4 2024 Q2Q % growth | -0.45 32.84% | -0.57 | 0.12 | 21.46% |
| Q3 2024 Q2Q % growth | -0.63 -16.67% | -0.78 | 0.15 | 19.53% |
| Q2 2024 Q2Q % growth | -0.69 14.81% | -0.75 | 0.06 | 7.69% |
| Q1 2024 Q2Q % growth | -0.62 20.51% | -0.72 | 0.10 | 13.77% |
| Q4 2023 Q2Q % growth | -0.67 -19.64% | -0.74 | 0.07 | 9.82% |
| Q3 2023 Q2Q % growth | -0.54 28.95% | -0.85 | 0.31 | 36.27% |
| Q2 2023 Q2Q % growth | -0.81 -14.08% | -0.83 | 0.02 | 2.64% |
| Q1 2023 Q2Q % growth | -0.78 -36.84% | -0.71 | -0.07 | -10.62% |
| Q4 2022 Q2Q % growth | -0.56 9.68% | -0.72 | 0.16 | 21.82% |
| Q3 2022 Q2Q % growth | -0.76 -15.15% | -0.72 | -0.04 | -5.60% |
| Q2 2022 Q2Q % growth | -0.71 66.19% | -0.64 | -0.07 | -10.74% |
| Q1 2022 Q2Q % growth | -0.57 -21.28% | -0.63 | 0.06 | 9.62% |
| Q4 2021 Q2Q % growth | -0.62 -188.57% | -0.59 | -0.03 | -5.10% |
| Q3 2021 Q2Q % growth | -0.66 -29.41% | -0.65 | -0.01 | -1.33% |
| Q2 2021 Q2Q % growth | -2.10 65.35% | -0.46 | -1.64 | -351.78% |
| Q1 2021 Q2Q % growth | -0.47 | -0.49 | 0.02 | 4.99% |
| Q4 2020 Q2Q % growth | 0.70 | 0.17 | 0.53 | 307.70% |
| Q3 2020 Q2Q % growth | -0.51 | -0.35 | -0.16 | -44.51% |
| Q2 2020 Q2Q % growth | -6.06 | -0.68 | -5.38 | -796.78% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 677K | 61.2K | 615.8K | 1,006.21% |
| Q1 2025 Q2Q % growth | 7.679M -23.26% | 10.2K | 7.669M | 75,184.31% |
| Q4 2024 Q2Q % growth | 6.202M | -6.202M | -100.00% | |
| Q3 2024 Q2Q % growth | -100.00% | 81.6K | -81.6K | -100.00% |
| Q2 2024 Q2Q % growth | -100.00% | 81.6K | -81.6K | -100.00% |
| Q1 2024 Q2Q % growth | 10.007M 4,327.88% | 79.336K | 9.928M | 12,513.51% |
| Q4 2023 Q2Q % growth | 25.546M -100.00% | 129.815K | -129.815K | -100.00% |
| Q3 2023 Q2Q % growth | 25.202M 7,312.35% | 375.697K | 24.826M | 6,608.07% |
| Q2 2023 Q2Q % growth | 119K -67.84% | 706.86K | -587.86K | -83.16% |
| Q1 2023 Q2Q % growth | 226K -46.19% | 191.76K | 34.24K | 17.86% |
| Q4 2022 Q2Q % growth | 250K -56.14% | 3.366M | -3.116M | -92.57% |
| Q3 2022 Q2Q % growth | 340K -49.25% | 1.689M | -1.349M | -79.87% |
| Q2 2022 Q2Q % growth | 370K -55.95% | 1.967M | -1.597M | -81.19% |
| Q1 2022 Q2Q % growth | 420K -55.79% | 170.003K | 249.997K | 147.05% |
| Q4 2021 Q2Q % growth | 570K -99.31% | 3.917M | -3.347M | -85.45% |
| Q3 2021 Q2Q % growth | 670K | 109.283K | 560.717K | 513.09% |
| Q2 2021 Q2Q % growth | 840K | 6.8M | -5.96M | -87.65% |
| Q1 2021 Q2Q % growth | 950K | 4.151M | -3.201M | -77.11% |
| Q4 2020 Q2Q % growth | 82.65M | 37.4M | 45.25M | 120.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 11.95% | 35% | 10.32% | 11.54% |
| Revenue | 220% | 380.05% | 11.87% | 38.58% |